Wed, Aug 20, 2014, 3:51 AM EDT - U.S. Markets open in 5 hrs 39 mins

Recent

% | $
Quotes you view appear here for quick access.

DexCom, Inc. (DXCM) Message Board

  • tmcg1367 tmcg1367 Feb 6, 2013 10:15 PM Flag

    Interesting analyst note

    This story was from 1-14-13.

    "Wunderlich Securities noted, “We are raising our price target on DexCom (DXCM) to $18 per share from $15, reflecting the strong, initial success of the G4 Platinum CGM and additional catalysts on the horizon in 2013. DXCM pre-announced very strong Q4 product revenues last week, and offered solid guidance for 2013. Strong patient acceptance of G4 will drive results, which could leave our 2013 estimates conservative. In addition, FDA approval for pediatric patients and approval of the integrated Animas (JNJ-NR) pump/CGM serve as additional catalysts on the horizon (not built into our current estimates). DXCM is well positioned for strong growth in 2013 and beyond, and we continue to view the company as one of the most attractive acquisition targets in our coverage.”

    DexCom closed on Friday at $14.82."

    Good luck, all.

 
DXCM
44.92+0.51(+1.15%)Aug 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.